These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1202609)

  • 1. Screening of cellular immunity in patients with rheumatoid arthritis by phytohaemagglutinin skin test.
    Kaćaki J; Budimir M; Berović Z
    Rheumatology; 1975; 6():72-9. PubMed ID: 1202609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis.
    Ponce de León D; Acevedo-Vásquez E; Sánchez-Torres A; Cucho M; Alfaro J; Perich R; Pastor C; Harrison J; Sánchez-Schwartz C
    Ann Rheum Dis; 2005 Sep; 64(9):1360-1. PubMed ID: 16100342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired cutaneous cell-mediated immunity in newly diagnosed rheumatoid arthritis.
    Coaccioli S; Di Cato L; Marioli D; Patucchi E; Pizzuti C; Ponteggia M; Puxeddu A
    Panminerva Med; 2000 Dec; 42(4):263-6. PubMed ID: 11294089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.
    Ponce de Leon D; Acevedo-Vasquez E; Alvizuri S; Gutierrez C; Cucho M; Alfaro J; Perich R; Sanchez-Torres A; Pastor C; Sanchez-Schwartz C; Medina M; Gamboa R; Ugarte M
    J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell mediated immunity in rheumatoid arthritis: Imparied lymphocyte responsiveness, humoral immunosuppressants, and correlations with clinical status in patients off drug therapy.
    Lloyd TM; Panush RS
    J Rheumatol; 1977; 4(3):231-44. PubMed ID: 926101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression of cell-mediated immunity in old age and the immunopathic diseases, lupus erythematosus, chronic hepatitis and rheumatoid arthritis.
    Toh BH; Roberts-Thomson IC; Mathews JD; Whittingham S; Mackay IR
    Clin Exp Immunol; 1973 Jun; 14(2):193-202. PubMed ID: 4577851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and humoral immunity to purified protein derivative (PPD) in PPD skin reactive and nonreactive patients with pulmonary tuberculosis: comparative analysis of antigen-specific lymphocyte proliferation and IgG antibodies.
    Boras Z; Juretić A; Rudolf M; Uzarević B; Trescec A
    Croat Med J; 2002 Jun; 43(3):301-5. PubMed ID: 12035136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with TNF-alpha blocking drugs using a novel flow-cytometric interferon-gamma release assay.
    Dinser R; Fousse M; Sester U; Albrecht K; Singh M; Köhler H; Müller-Ladner U; Sester M
    Rheumatology (Oxford); 2008 Feb; 47(2):212-8. PubMed ID: 18208824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved efficiency in detecting cellular immunity towards M. tuberculosis in patients receiving immunosuppressive drug therapy.
    Sester U; Junker H; Hodapp T; Schütz A; Thiele B; Meyerhans A; Köhler H; Sester M
    Nephrol Dial Transplant; 2006 Nov; 21(11):3258-68. PubMed ID: 16935889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro lymphocyte reactivity to PPD and phytohaemagglutinin in relation to PPD skin reactivity and age.
    Nilsson BS
    Scand J Respir Dis; 1971; 52(1):39-47. PubMed ID: 5566507
    [No Abstract]   [Full Text] [Related]  

  • 11. Infliximab does not suppress the tuberculin skin test (purified protein derivative).
    Hatemi G; Melikoglu M; Fresko I; Masatlioglu S; Tascilar K; Yazici H
    J Rheumatol; 2007 Mar; 34(3):474-80. PubMed ID: 17299840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular immune reactivity in patients with rheumatoid arthritis and effects of levamisole.
    Basch CM; Spitler LE; Engleman EG; Engleman EP
    J Rheumatol; 1977; 4(4):377-88. PubMed ID: 604477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular immunity to the G1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate.
    Guerassimov A; Zhang Y; Banerjee S; Cartman A; Leroux JY; Rosenberg LC; Esdaile J; Fitzcharles MA; Poole AR
    Arthritis Rheum; 1998 Jun; 41(6):1019-25. PubMed ID: 9627011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunological approach to chronic rheumatic polyarthritis: 1st results].
    Serre H; Simon L; Mandin J; Sany J; Clot J
    Rev Rhum Mal Osteoartic; 1972 Feb; 39(2):91-100. PubMed ID: 4628427
    [No Abstract]   [Full Text] [Related]  

  • 15. Interleukin-2 reverses deficient cell-mediated immune responses in rheumatoid arthritis.
    Emery P; Panayi GS; Nouri AM
    Clin Exp Immunol; 1984 Jul; 57(1):123-9. PubMed ID: 6611230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of HLA-DR4 to defective cellular immunity in rheumatoid arthritis using PPD, and mycoplasma and lectin mitogens.
    Emery P; Panayi GS; Welsh KI; Cole BC
    J Rheumatol; 1985 Oct; 12(5):859-64. PubMed ID: 3878876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis.
    Abdel-Nasser AM; Mahmoud MH; El Mansoury TM; Osman AM
    Scand J Rheumatol; 2008; 37(5):329-36. PubMed ID: 18666028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated immune response to tuberculosis antigens: comparison of skin testing and measurement of in vitro gamma interferon production in whole-blood culture.
    Katial RK; Hershey J; Purohit-Seth T; Belisle JT; Brennan PJ; Spencer JS; Engler RJ
    Clin Diagn Lab Immunol; 2001 Mar; 8(2):339-45. PubMed ID: 11238218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of cellular immunity to prognosis in acute leukemia.
    Toki H; Takahashi Y; Nakanishi N; Naito T; Chen P; Takahashi I; Kitajima K
    Acta Med Okayama; 1977 Feb; 31(1):51-8. PubMed ID: 140590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of nonspecific cell-mediated immunity in cancer patients. I. Frequent dissociation between the responses of skin tests to recall antigens and in vitro lymphocyte transformation.
    Simmler MC; Rameau G; Chou MJ; Mathé G
    Isr J Med Sci; 1976; 12(4-5):472-8. PubMed ID: 939695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.